Known targets — ChEMBL curated mechanism
CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1SLC9A3
The experimentally established mechanism targets of L-Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 4/20 | 0.38 |
| ▸ | CA4 | P22748 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| L-Lactic Acid SCHEMBL407991 | 1.00 | TP53 (0.47) | TP53CA1CA4CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL5013207 | 1.00 | TP53 (0.47) | TP53CA1CA4CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL1292751 | 1.00 | TP53 (0.47) | TP53CA1CA4CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL29655228 | 0.96 | TP53 (0.50) | TP53CA1CA4CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL191421 | 0.96 | TP53 (0.50) | TP53CA1CA4CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL29508771 | 0.96 | TP53 (0.50) | TP53CA1CA4CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL25270068 | 0.93 | — | — | |
| L-Lactic Acid SCHEMBL407161 | 0.93 | TP53 (0.47) | TP53CA1CA4CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL8462013 | 0.93 | — | — | |
| L-Lactic Acid SCHEMBL14119668 | 0.93 | TP53 (0.47) | TP53CA1CA4CA2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116096478-B | Adsorbent for copper, iron and nitrogen treatment and preparation method thereof | CALGON CARBON CORP. (US) | 2026-05-26 | — | — | CN | claimed |
| US-12064745-B2 | Iron and nitrogen treated sorbent and method for making same | CALGON CARBON CORPORATION (US) | 2024-08-20 | — | — | US | claimed |
| EP-4204122-A2 | IRON AND NITROGEN TREATED SORBENT AND METHOD FOR MAKING SAME | Calgon Carbon Corporation (US) | 2023-07-05 | — | — | EP | claimed |
| CN-116234626-A | Iron and nitrogen treated adsorbent and method for preparing same | 卡尔冈碳素公司 | 2023-06-06 | — | — | CN | claimed |
| CN-116096478-A | Adsorbent for copper, iron and nitrogen treatment and preparation method thereof | 卡尔冈碳素公司 | 2023-05-09 | — | — | CN | claimed |
| WO-2022047499-A2 | IRON AND NITROGEN TREATED SORBENT AND METHOD FOR MAKING SAME | CALGON CARBON CORPORATION (US) | 2022-03-03 | — | — | WO | claimed |
| US-20220062855-A1 | IRON AND NITROGEN TREATED SORBENT AND METHOD FOR MAKING SAME | CALGON CARBON CORPORATION (US) | 2022-03-03 | — | — | US | claimed |
| CN-111938142-A | Full-nutrient product and its production method | 南京领跑生命健康产业技术研究院有限公司 | 2020-11-17 | — | — | CN | claimed |
| WO-2015020516-A1 | IMPROVED POLLEN AND/OR POLLEN SUBSTITUTE COMPRISING BEE FOOD COMPOSITION | SUSTAIN B.V. (NL) | 2015-02-12 | — | — | WO | claimed |
| US-6875253-B2 | Metal alloy fine particles and method for producing thereof | HITACHI MAXELL, LTD. (JP) | 2005-04-05 | — | — | US | claimed |
| US-20040074336-A1 | Metal alloy fine particles and method for producing thereof | HITACHI MAXELL, LTD. (JP) | 2004-04-22 | — | — | US | claimed |
| CN-116096478-B | Adsorbent for copper, iron and nitrogen treatment and preparation method thereof | CALGON CARBON CORP. (US) | 2026-05-26 | — | — | CN | disclosed |
| US-20260137715-A1 | AQUEOUS FORMULATION INCLUDING DISSOLVED HYDROGEN GAS AND MINERALS AND ADDITIVES | BEST PLANET SCIENCE LLC (US) | 2026-05-21 | — | — | US | disclosed |
| US-12527815-B2 | Aqueous formulation including dissolved hydrogen gas and minerals and additives | BEST PLANET SCIENCE LLC (US) | 2026-01-20 | — | — | US | disclosed |
| US-12064745-B2 | Iron and nitrogen treated sorbent and method for making same | CALGON CARBON CORPORATION (US) | 2024-08-20 | — | — | US | disclosed |
| EP-1184408-A2 | Anti-fog resin sheet, anti-fog agent and molded article | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2002-03-06 | — | — | EP | disclosed |
| US-6310156-B1 | CATALYTIC ADDITION POLYMERIZATION OF (METH)ACRYLIC ACID WITH PERSULFATE AND BISULFITE SALTS | NIPPON SHOKUBAI CO., LTD. (JP) | 2001-10-30 | — | — | US | disclosed |
| EP-0942015-A2 | (Meth)acrylic acid polymer and manufacturing method thereof | Nippon Shokubai Co., Ltd. (JP) | 1999-09-15 | — | — | EP | disclosed |
| US-5562820-A | Process for purifying water | AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1996-10-08 | — | — | US | disclosed |
| US-5449467-A | Process for purifying water | DIRECTOR GENERAL OF AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1995-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260137715-A1 | AQUEOUS FORMULATION INCLUDING DISSOLVED HYDROGEN GAS AND MINERALS AND ADDITIVES | SDHB, ABCB7, SLC9B2 | TP53 1802/4885CA1 10/4885CA4 361/4885 |
| US-12527815-B2 | Aqueous formulation including dissolved hydrogen gas and minerals and additives | SLC7A11, SDHB, LDHB | TP53 980/4885CA1 53/4885CA4 740/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.